
Opinion|Videos|February 28, 2025
Brief Overview of Current Treatment Landscape and Unmet Needs in R/R Large B-Cell Lymphoma
Author(s)Mazyar Shadman, MD, MPH, Melody Smith, MD, MS
Experts provide a brief overview of the current treatment landscape and unmet needs in relapsed/refractory (R/R) large B-cell lymphoma.
Advertisement
Episodes in this series

Now Playing
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
EC Approves Encorafenib/Cetuximab/FOLFOX in 1L BRAF V600E–Mutant mCRC
2
Zanzalintinib/Atezolizumab Misses Survival End Point in Non-MSI-H mCRC Subgroup
3
Sigvotatug Vedotin Does Not Significantly Improve Survival in NSCLC Trial
4
The Moonlight Shift: Dr Joshua Richter on Myeloma, Myths, and the C-Word
5



















































































